PL2310017T3 - Nifurtymoks do leczenia chorób powodowanych przez trichomonadida - Google Patents

Nifurtymoks do leczenia chorób powodowanych przez trichomonadida

Info

Publication number
PL2310017T3
PL2310017T3 PL09772098T PL09772098T PL2310017T3 PL 2310017 T3 PL2310017 T3 PL 2310017T3 PL 09772098 T PL09772098 T PL 09772098T PL 09772098 T PL09772098 T PL 09772098T PL 2310017 T3 PL2310017 T3 PL 2310017T3
Authority
PL
Poland
Prior art keywords
trichomonadida
nifurtimox
diseases caused
treating diseases
treating
Prior art date
Application number
PL09772098T
Other languages
English (en)
Inventor
Achim Harder
Gisela Greif
Robrecht Froyman
Original Assignee
Bayer Ip Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ip Gmbh filed Critical Bayer Ip Gmbh
Publication of PL2310017T3 publication Critical patent/PL2310017T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/541—Non-condensed thiazines containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/15—Depsipeptides; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/10—Anthelmintics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Fodder In General (AREA)
  • Plural Heterocyclic Compounds (AREA)
PL09772098T 2008-07-02 2009-06-20 Nifurtymoks do leczenia chorób powodowanych przez trichomonadida PL2310017T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE102008031283A DE102008031283A1 (de) 2008-07-02 2008-07-02 Neue Bekämpfungsmöglichkeit von durch Trichomonadida hervorgerufenen Krankheiten
EP09772098.1A EP2310017B1 (de) 2008-07-02 2009-06-20 Nifurtimox zur behandlung von durch trichomonadida hervorgerufenen krankheiten
PCT/EP2009/004474 WO2010000398A1 (de) 2008-07-02 2009-06-20 Nifurtimox zur behandlung von durch trichomonadida hervorgerufenen krankheiten

Publications (1)

Publication Number Publication Date
PL2310017T3 true PL2310017T3 (pl) 2013-08-30

Family

ID=41092164

Family Applications (1)

Application Number Title Priority Date Filing Date
PL09772098T PL2310017T3 (pl) 2008-07-02 2009-06-20 Nifurtymoks do leczenia chorób powodowanych przez trichomonadida

Country Status (26)

Country Link
US (1) US8440613B2 (pl)
EP (1) EP2310017B1 (pl)
JP (1) JP5571659B2 (pl)
KR (1) KR20110031360A (pl)
CN (1) CN102083440B (pl)
AR (1) AR072426A1 (pl)
AU (1) AU2009266124B2 (pl)
CA (1) CA2729727A1 (pl)
CL (1) CL2010001594A1 (pl)
CO (1) CO6321268A2 (pl)
CR (1) CR20110023A (pl)
DE (1) DE102008031283A1 (pl)
DK (1) DK2310017T3 (pl)
DO (1) DOP2010000406A (pl)
EC (1) ECSP10010721A (pl)
ES (1) ES2415231T3 (pl)
IL (1) IL209999A0 (pl)
MX (1) MX2010014444A (pl)
NI (1) NI201100009A (pl)
PE (1) PE20110370A1 (pl)
PL (1) PL2310017T3 (pl)
RU (1) RU2538712C2 (pl)
SV (1) SV2011003784A (pl)
UA (1) UA103197C2 (pl)
WO (1) WO2010000398A1 (pl)
ZA (1) ZA201009226B (pl)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2633855A1 (en) 2012-03-01 2013-09-04 Veterinärmedizinische Universität Wien Protease inhibitors for treating Trichomonas gallinae infections
SI3298027T1 (sl) * 2015-05-20 2021-08-31 Boehringer Ingelheim Animal Health USA Inc. Antihelmintične depsipeptidne spojine
WO2017116702A1 (en) 2015-12-28 2017-07-06 Merial, Inc. Anthelmintic depsipeptide compounds
JP6085706B1 (ja) * 2016-03-31 2017-02-22 株式会社ポーラファルマ 抗トリトリコモナス剤
CN110167921A (zh) 2016-11-16 2019-08-23 勃林格殷格翰动物保健美国公司 驱蠕虫缩肽化合物

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1170957B (de) 1962-11-23 1964-05-27 Bayer Ag Verfahren zur Herstellung von 5-Nitro-furfuryliden-(2)-iminoderivaten
NO176766C (no) * 1989-02-07 1995-05-24 Meiji Seika Kaisha Fremgangsmåte for fremstilling av en forbindelse med anthelmintaktivitet
CA2132199C (en) 1992-03-17 2000-01-18 Hitoshi Nishiyama Depsipeptide derivative, production thereof and use thereof
DE4317458A1 (de) * 1992-06-11 1993-12-16 Bayer Ag Verwendung von cyclischen Depsipeptiden mit 18 Ringatomen zur Bekämpfung von Endoparasiten, neue cyclische Depsipeptide mit 18 Ringatomen und Verfahren zu ihrer Herstellung
NZ261630A (en) * 1993-02-19 1998-05-27 Meiji Seika Kaisha Heteromacrocyclic compound and use as an assthelmintie
DE4317432A1 (de) * 1993-05-26 1994-12-01 Bayer Ag Octacyclodepsipeptide mit endoparasitizider Wirkung
DE4317457A1 (de) 1993-05-26 1994-12-01 Bayer Ag Octacyclodepsipeptide mit endoparasitizider Wirkung
ES2170101T3 (es) 1993-09-06 2002-08-01 Fujisawa Pharmaceutical Co Compuesto ciclodepsipeptido.
DE4401389A1 (de) * 1994-01-19 1995-07-20 Bayer Ag Verwendung von cyclischen Depsipeptiden mit 12 Ringatomen zur Bekämpfung von Endoparasiten, neue cyclische Depsipeptide mit 12 Ringatomen und Verfahren zu ihrer Herstellung
DE4406025A1 (de) * 1994-02-24 1995-08-31 Bayer Ag Milchsäure-haltige cyclische Depsipeptide mit 18 Ringatomen als endoparasitizide Mittel und Verfahren zu ihrer Herstellung
RU2074038C1 (ru) * 1994-06-16 1997-02-27 Товарищество с ограниченной ответственностью Предприятие "ТЕПАРК" Способ изготовления полых металлических емкостей
DE4437198A1 (de) * 1994-10-18 1996-04-25 Bayer Ag Verfahren zur Sulfonylierung, Sulfenylierung und Phosphorylierung von cyclischen Depsipeptiden
JP3985050B2 (ja) * 1995-06-30 2007-10-03 アステラス製薬株式会社 デプシペプチド誘導体その製造法およびその新規中間体
CZ295705B6 (cs) 1995-09-22 2005-10-12 Bayer Aktiengesellschaft Cyklodepsipeptidové deriváty sloučeniny PF1022 a farmaceutický prostředek s jejich obsahem
DE19545639A1 (de) * 1995-12-07 1997-06-12 Bayer Ag Verfahren zur Herstellung von substituierten Arylmilchsäure-haltigen Cyclodepsipeptiden mit 24 Ringatomen
US6503881B2 (en) * 1996-08-21 2003-01-07 Micrologix Biotech Inc. Compositions and methods for treating infections using cationic peptides alone or in combination with antibiotics
UA5478U (uk) * 2004-06-21 2005-03-15 Ігор Едуардович Лук'янов Спосіб лікування хворих на урогенітальний трихомоніаз
AU2005304420A1 (en) * 2004-11-12 2006-05-18 Celgene Corporation Methods and compositions using immunomodulatory compounds for treatment and management of parasitic diseases

Also Published As

Publication number Publication date
DE102008031283A1 (de) 2010-01-07
JP2011526264A (ja) 2011-10-06
CR20110023A (es) 2011-05-10
US8440613B2 (en) 2013-05-14
NI201100009A (es) 2011-08-10
EP2310017B1 (de) 2013-05-15
ZA201009226B (en) 2012-03-23
DK2310017T3 (da) 2013-07-01
CL2010001594A1 (es) 2011-05-06
CA2729727A1 (en) 2010-01-07
CN102083440A (zh) 2011-06-01
CN102083440B (zh) 2013-03-27
MX2010014444A (es) 2011-02-22
CO6321268A2 (es) 2011-09-20
RU2011103476A (ru) 2012-08-10
AU2009266124B2 (en) 2015-03-19
RU2538712C2 (ru) 2015-01-10
AU2009266124A1 (en) 2010-01-07
PE20110370A1 (es) 2011-06-22
WO2010000398A1 (de) 2010-01-07
SV2011003784A (es) 2011-05-20
JP5571659B2 (ja) 2014-08-13
KR20110031360A (ko) 2011-03-25
AR072426A1 (es) 2010-08-25
US20110118176A1 (en) 2011-05-19
DOP2010000406A (es) 2011-01-15
ES2415231T3 (es) 2013-07-24
ECSP10010721A (es) 2011-01-31
UA103197C2 (uk) 2013-09-25
EP2310017A1 (de) 2011-04-20
IL209999A0 (en) 2011-02-28

Similar Documents

Publication Publication Date Title
PT2252148T (pt) Métodos de tratamento da síndrome do intestino irritável
EP2320907A4 (en) THERAPEUTIC COMPOUNDS
IL212348A0 (en) Treatment method
IL209895A0 (en) Compounds for treating beta-amyloidoses
IL213619A0 (en) Treatment
GB0802116D0 (en) Treatment
EP2365747A4 (en) METHODS OF TREATING GASTROINTESTINAL DISEASES
EP2268285A4 (en) THERAPEUTIC COMPOUNDS
EP2307035A4 (en) TREATMENT OF EPILEPSY
IL214919A0 (en) Method for therapeutic use
GB0822011D0 (en) Treatment
GB0806794D0 (en) Therapeutic compounds
GB0813740D0 (en) Therapeutic compounds
EP2341936A4 (en) METHOD FOR TREATING OR PREVENTING IL-1ß-CONTAINED ILLNESSES
GB0804755D0 (en) Therapeutic compounds
PL2247297T3 (pl) Działanie terapeutyczne w stanach chorobowych płuc
ZA201204845B (en) Agents for treating disease
GB0811992D0 (en) Treatment
IL209999A0 (en) Nifurtimox for treating diseases caused by trichomonadida
EP2255825A4 (en) COMPOSITION FOR PREVENTING OR TREATING BRAIN DISEASES
IL209947A (en) Compounds for the treatment of corneal inflammation
EP2240192A4 (en) TREATMENT OF DERMATOLOGICAL SUFFERING
IL207906A0 (en) Treatment for ocular-related disorders
GB0820972D0 (en) Treatment
IL213287A0 (en) Treatment for glomerulonephritis